Perspective Therapeutics Inc (CATX) - News Archive

Seattle-based Perspective Therapeutics, Inc. has announced that its senior leadership team is set to participate in several investor conferences slated for May. The radiopharmaceutical company, a player in the medical i...

Perspective Therapeutics, a pioneering radiopharmaceutical company specializing in advanced cancer treatments, is set to provide an update on its recent business highlights and report its first quarter 2024 financial re...

The company revealed the news on April 30, 2024, drawing attention to its continued pioneering efforts in creating advanced therapeutic applications for various forms of cancer. The FDA’s decision to include Perspective...

In a significant development, Perspective Therapeutics, a pioneering radiopharmaceutical company, announced an investment agreement with a group of institutional accredited investors. The company aims to raise approxima...

Operating under its company label on the NYSE American as CATX, Perspective Therapeutics confidently strides on its quest to innovate and revolutionize the realm of cancer therapeutics through its adept usage of medical...